About this trial
After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guideline. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up.
The HAKA trial consists of three different work packages (WPs). This trial (WP2) investigates the 10-year follow-up, WP1 examines the 1-year follow-up, and WP3 is a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. The aim of the HAKA trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.
Eligibility criteria
Qualifiers
Underwent primary THA or TKA approximately 10 years ago
Age 50 years or older at time of THA or TKA
Capable and willing to complete questionnaires (when applicable)
Understanding Dutch or English
Disqualifiers
Other indication for surgery than osteoarthritis
Deceased
Revision arthroplasty of hip or knee, except a conversion from unicompartmental knee arthroplasty to TKA or from hip hemiarthroplasty/resurfacing to THA
Already participating in this study due to another hip or knee surgery
Trial design
Treatments tested in this trial
- Routine Follow-Up (RFU)
- Active Check-Up on Demand (ACOD)
- Passive Check-Up on Demand (PCOD)
Treatment groups
Sponsors and collaborators
Reinier Haga Orthopedisch Centrum
Lead sponsor
JointResearch
Collaborator
Tergooi Medical Center
Collaborator